A multi-locus predictiveness curve and its summary assessment for genetic risk prediction
By: Changshuai Wei , Ming Li , Yalu Wen and more
Potential Business Impact:
Helps predict diseases using many genes.
With the advance of high-throughput genotyping and sequencing technologies, it becomes feasible to comprehensive evaluate the role of massive genetic predictors in disease prediction. There exists, therefore, a critical need for developing appropriate statistical measurements to access the combined effects of these genetic variants in disease prediction. Predictiveness curve is commonly used as a graphical tool to measure the predictive ability of a risk prediction model on a single continuous biomarker. Yet, for most complex diseases, risk prediciton models are formed on multiple genetic variants. We therefore propose a multi-marker predictiveness curve and provide a non-parametric method to construct the curve for case-control studies. We further introduce a global predictiveness U and a partial predictiveness U to summarize prediction curve across the whole population and sub-population of clinical interest, respectively. We also demonstrate the connections of predictiveness curve with ROC curve and Lorenz curve. Through simulation, we compared the performance of the predictiveness U to other three summary indices: R square, Total Gain, and Average Entropy, and showed that Predictiveness U outperformed the other three indexes in terms of unbiasedness and robustness. Moreover, we simulated a series of rare-variants disease model, found partial predictiveness U performed better than global predictiveness U. Finally, we conducted a real data analysis, using predictiveness curve and predictiveness U to evaluate a risk prediction model for Nicotine Dependence.
Similar Papers
Predictiveness Curve Assessment under Competing Risks for Risk Prediction Models
Methodology
Shows how likely patients are to get sick.
Collapsing ROC approach for risk prediction research on both common and rare variants
Machine Learning (CS)
Finds disease risks using all gene types.
Predictive biomarker graphical approach (PRIME) for Precision medicine
Methodology
Finds best medicine for each person.